XML 129 R20.htm IDEA: XBRL DOCUMENT

CONCENTRATIONS

6 Months Ended

Jun. 30, 2013

Concentration Risk Disclosure [Text Block]

15.

CONCENTRATIONS

Major Customers

For the six months ended June 30, 2013 and 2012, approximately 18% and 10% of the Company’s revenues were received from each of two customers.

No customer represented more than 10% of amounts receivable at June 30, 2013. At December 31, 2012, receivables from two customers were approximately 12% and 10%, respectively.

Revenues

For the six months ended June 30, 2013 and 2012, the Company’s top three selling products accounted, in the aggregate, for approximately 65% and 76%, respectively, of its total net revenues.

The following represents the revenues by product line, all derived from China:

	For the six months ended June 30,
	2013		2012
	US$		US$
Products Line
Medical Devices		7,138,474		8,687,340
Respiratory and Oxygen Homecare		1,186,908		1,611,719
		8,325,382		10,299,059

- Definition

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

+ References+ Details